Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection

Genetic Dissection of Azole Resistance Mechanisms in Candida albicans and Their Validation in a Mouse Model of Disseminated Infection

(2010) D. M. MacCallum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

(2010) Maiken Cavling Arendrup et al.   PLoS One

Comparison of Assessment of Oxygen Consumption, Etest, and CLSI M38-A2 Broth Microdilution Methods for Evaluation of the Susceptibility of Aspergillus fumigatus to Posaconazole

(2009) R. Araujo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Efflux-Mediated Antifungal Drug Resistance

(2009) R. D. Cannon et al.   CLINICAL MICROBIOLOGY REVIEWS

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

(2009) Dominique Sanglard et al.   FEMS YEAST RESEARCH

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective Concentration

(2009) J. Fuller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus

(2008) J. L. Rodriguez-Tudela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification

(2008) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

(2008)   CLINICAL MICROBIOLOGY AND INFECTION

Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatus

(2008) G. Garcia-Effron et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE